Cargando…
Hutchinson-Gilford Progeria Syndrome—Current Status and Prospects for Gene Therapy Treatment
Hutchinson-Gilford progeria syndrome (HGPS) is one of the most severe disorders among laminopathies—a heterogeneous group of genetic diseases with a molecular background based on mutations in the LMNA gene and genes coding for interacting proteins. HGPS is characterized by the presence of aging-asso...
Autores principales: | Piekarowicz, Katarzyna, Machowska, Magdalena, Dzianisava, Volha, Rzepecki, Ryszard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406247/ https://www.ncbi.nlm.nih.gov/pubmed/30691039 http://dx.doi.org/10.3390/cells8020088 |
Ejemplares similares
-
Hutchinson-Gilford progeria syndrome
por: Bhukya, Amar Singh, et al.
Publicado: (2015) -
Ocular manifestations in the Hutchinson-Gilford progeria syndrome
por: Chandravanshi, Shivcharan L, et al.
Publicado: (2011) -
Metabolic Dysfunction in Hutchinson–Gilford Progeria Syndrome
por: Kreienkamp, Ray, et al.
Publicado: (2020) -
Progress and trends in the development of therapies for Hutchinson–Gilford progeria syndrome
por: Lai, Wing‐Fu, et al.
Publicado: (2020) -
Isoprenylcysteine Carboxylmethyltransferase-Based
Therapy for Hutchinson–Gilford Progeria Syndrome
por: Marcos-Ramiro, Beatriz, et al.
Publicado: (2021)